Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroscience

• Publication date

  2007-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NEUROSCIENCE.2007.08.021PMID 17900813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deletion of the c-Jun N-terminal Kinase 3 Gene Protects Neonatal Mice against Cerebral Hypoxic—Ischaemic Injury

  2007cited by this paper
• Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons

  2007cited by this paper
• Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis.

  2006cited by this paper
• Correction: A Signaling Network for Patterning of Neuronal Connectivity in the Drosophila Brain

  2006cited by this paper
• JNK pathway as therapeutic target to prevent degeneration in the central nervous system.

  2006cited by this paper
• A Signaling Network for Patterning of Neuronal Connectivity in the Drosophila Brain

  2006cited by this paper
• Control of death receptor and mitochondrial‐dependent apoptosis by c‐Jun N‐terminal kinase in hippocampal CA1 neurones following global transient ischaemia

  2005cited by this paper
• Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides.

  2005cited by this paper
• Specific pathophysiological functions of JNK isoforms in the brain

  2005cited by this paper
• Peptide-enhanced cellular internalization of proteins in neuroscience.

  2005cited by this paper
• Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?".

  2005cited by this paper
• Activated mitogen‐activated protein kinase kinase 7 redistributes to the cytosol and binds to Jun N‐terminal kinase‐interacting protein 1 involving oxidative stress during early reperfusion in rat hippocampal CA1 region

  2005cited by this paper
• The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region.

  2005cited by this paper
• Neuroprotection against Focal Ischemic Brain Injury by Inhibition of c-Jun N-Terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway

  2005cited by this paper
• c‐Jun N‐terminal kinases (JNKs) and the cytoskeleton—functions beyond neurodegeneration

  2004cited by this paper
• The c-Jun N-Terminal Protein Kinase Signaling Pathway Mediates Bax Activation and Subsequent Neuronal Apoptosis through Interaction with Bim after Transient Focal Cerebral Ischemia

  2004cited by this paper
• Delivery of bioactive molecules into the cell: the Trojan horse approach.

  2004cited by this paper
• Use of cell-permeable peptides to prevent neuronal degeneration.

  2004cited by this paper
• A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia

  2003cited by this paper
• N‐methyl‐d‐aspartate‐triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c‐Jun N‐terminal kinase pathway

  2003cited by this paper
• Cellular and molecular events underlying ischemia-induced neuronal apoptosis.

  2003cited by this paper
• Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma.

  2003cited by this paper
• Activation of the JNK signaling pathway: Breaking the brake on apoptosis

  2003cited by this paper
• A critical role of neural-specific JNK3 for ischemic apoptosis

  2003cited by this paper
• JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis.

  2003cited by this paper
• A Peptide Inhibitor of c-Jun N-Terminal Kinase Protects against Both Aminoglycoside and Acoustic Trauma-Induced Auditory Hair Cell Death and Hearing Loss

  2003cited by this paper
• Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases.

  2002cited by this paper
• Role of Mitogen- and Stress-Activated Kinases in Ischemic Injury

  2002cited by this paper
• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

  2001cited by this paper
• Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

  2001cited by this paper
• Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of β-Cell Death

  2001cited by this paper
• Mammalian MAP kinase signalling cascades

  2001cited by this paper
• Dual Roles for c-Jun N-Terminal Kinase in Developmental and Stress Responses in Cerebellar Granule Neurons

  2000cited by this paper
• A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat: morphological changes indicative of apoptosis.

  1998influential reference
• The c-Jun transcription factor--bipotential mediator of neuronal death, survival and regeneration.

  1997cited by this paper
• Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli.

  1997cited by this paper
• Neuron imaging with Neurolucida--a PC-based system for image combining microscopy.

  1990cited by this paper

• Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors

  2025cites this paper
• Caryocar brasiliense peel ethanolic extract has neuroprotective potential and reduces the activation of ERK1/2 in the ischemia and reperfusion brain acute phase in the rat.

  2023cites this paper
• Proteome profiling of hippocampus reveals the neuroprotective effect of mild hypothermia on global cerebral ischemia–reperfusion injury in rats

  2023cites this paper
• Treponema denticola Induces Neuronal Apoptosis by Promoting Amyloid-β Accumulation in Mice

  2022cites this paper
• Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion

  2021cites this paper
• Extrinsic and intrinsic pathways of apoptosis and related molecules in ischemic stroke

  2021cites this paper
• c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination

  2021cites this paper
• Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases

  2021cites this paper
• Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases.

  2021cites this paper
• The pivotal role of SUMO-1-JNK-Tau axis in an in vitro model of oxidative stress counteracted by the protective effect of curcumin.

  2020cites this paper
• Wnt Pathway: An Emerging Player in Vascular and Traumatic Mediated Brain Injuries

  2020cites this paper
• JNK Signaling Pathway Involvement in Spinal Cord Neuron Development and Death

  2019cites this paper
• Apoptotic cell death regulation in neurons

  2019cites this paper
• Peptide-mediated neuroprotection against excitotoxicity and cerebral ischemia by regulation of the JNK-activation cascade

  2019cites this paper
• Specific Alterations in Astrocyte Properties via the GluA2-GAPDH Complex Associated with Multiple Sclerosis

  2018cites this paper
• The MKK7 inhibitor peptide GADD45β-I attenuates ER stress-induced mitochondrial dysfunction in HT22 cells: Involvement of JNK-Wnt pathway.

  2018cites this paper
• Identification of Novel LncRNA Biomarkers and Construction of LncRNA-Related Networks in Han Chinese Patients with Ischemic Stroke

  2018cites this paper
• Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour

  2018cites this paper
• Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders.

  2018cites this paper
• Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice

  2018influential citation
• Utilizing Delta Opioid Receptors and Peptides for Cytoprotection: Implications in Stroke and Other Neurological Disorders.

  2017cites this paper
• Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats

  2017cites this paper
• Brain Edema in Developing Brain Diseases

  2017cites this paper
• JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid

  2017cites this paper
• Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration.

  2017influential citation
• Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy.

  2017cites this paper
• Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase

  2017cites this paper
• Effectiveness of minocycline in acute white matter injury after intracerebral hemorrhage.

  2016cites this paper
• Tongluoxingnao effervescent tablets ameliorate learning and memory impairment in a rat model of vascular dementia via the regulation of the p 38 and ERK MAPK signaling pathways

  2016cites this paper
• JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic niche

  2016cites this paper
• JNK regulation of neurogenesis, neuroplasticity and anxiety-related behaviors in mice

  2016cites this paper
• Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release

  2015cites this paper
• Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis

  2015cites this paper
• Differential Relevance of NF-κB and JNK in the Pathophysiology of Hemorrhage/Resususcitation-Induced Liver Injury after Chronic Ethanol Feeding

  2015cites this paper
• Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury

  2015cites this paper
• Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.

  2015cites this paper
• Neuroprotective Potential of Withania Somnifera in Cerebral Ischemia

  2014cites this paper
• c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo

  2014cites this paper
• Molecular Mechanisms Underlying in vitro Cerebral Ischemia: Multiple Neuronal Death Pathways

  2014cites this paper
• Nuclear and cytosolic JNK signalling in neurons

  2014cites this paper
• Bioportides: Bioactive cell‐penetrating peptides that modulate cellular dynamics

  2013cites this paper
• Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage.

  2013influential citation
• DIDS (4,4-Diisothiocyanatostilbenedisulphonic Acid) Induces Apoptotic Cell Death in a Hippocampal Neuronal Cell Line and Is Not Neuroprotective against Ischemic Stress

  2013cites this paper
• TRAF1 is a critical regulator of cerebral ischaemia–reperfusion injury and neuronal death

  2013cites this paper
• A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease

  2013cites this paper
• Role of JNK isoforms in the development of neuropathic pain following sciatic nerve transection in the mouse

  2012cites this paper
• Cell-specific siRNA delivery by peptides and antibodies.

  2012cites this paper
• Autophagy and Apoptosis Are Differentially Induced in Neurons and Astrocytes Treated with an In Vitro Mimic of the Ischemic Penumbra

  2012cites this paper
• JNK signaling is the shared pathway linking neuroinflammation, blood–brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the immature brain

  2012cites this paper
• The JNK signalling transduction pathway in the brain.

  2012cites this paper
• Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury.

  2012cites this paper
• Delivery of neurotherapeutics across the blood brain barrier in stroke.

  2012cites this paper
• Reticulon 1C induces Disruption of Ca2+ Signaling and Alteration in Mitochondrial Dynamics in vitro and Neurodegeneration in vivo

  2012cites this paper
• Inflammatory activation of the cerebrovascular endothelium in response to oxygen-glucose deprivation

  2012cites this paper
• Peptides targeting the mitogen-activated protein kinase pathway (JNK/Jun) fail to reduce infarct volume after permanent MCAO in Sprague Dawley rats

  2012cites this paper
• Bioengineering of a TAT-conjugated Peptide to Modulate the Activity of Glycogen Synthase Kinase-3 in Adult and Embryonic Stem Cells

  2011cites this paper
• JNK3 as a Therapeutic Target for Neurodegenerative Diseases

  2011cites this paper
• Protection Against Ischemic Cochlear Damage by Intratympanic Administration of AM-111

  2011cites this paper
• Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug.

  2011cites this paper
• JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer's Disease Models

  2011cites this paper
• c-Jun N-Terminal Kinase (JNK) and p38 Play Different Roles in Age-Related Purkinje Cell Death in Murine Organotypic Culture

  2011cites this paper
• Protection by neuroglobin and cell-penetrating peptide-mediated delivery in vivo: a decade of research. Comment on Cai et al: TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp Neurol. 2011; 227(1): 224-31.

  2011cites this paper
• Lack of Neuroprotection of Inhibitory Peptides Targeting Jun/JNK after Transient Focal Cerebral Ischemia in Spontaneously Hypertensive Rats

  2011cites this paper
• c-Jun N-terminal Kinase Regulates Soluble Aβ Oligomers and Cognitive Impairment in AD Mouse Model*

  2011cites this paper
• JNK regulates FoxO-dependent autophagy in neurons.

  2011cites this paper
• Crosstalk between JNK and SUMO Signaling Pathways: deSUMOylation Is Protective against H2O2-Induced Cell Injury

  2011cites this paper
• Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain

  2010cites this paper
• JNK inhibition and inflammation after cerebral ischemia.

  2010cites this paper
• LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia.

  2010cites this paper
• c‐Jun N‐terminal kinase signaling pathway in excitotoxic cell death following kainic acid‐induced status epilepticus

  2010cites this paper
• Neuroprotection of the newborn brain: therapeutic targets & behavioral outcome

  2010cites this paper
• The c‐Jun N‐terminal kinase (JNK) inhibitor XG‐102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats

  2010cites this paper
• Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury.

  2010cites this paper
• c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges.

  2010cites this paper
• Specific activities of individual c-Jun N-terminal kinases in the brain.

  2009cites this paper
• 14 Cell-Penetrating Peptides — Uptake , Toxicity , and Applications

  2009cites this paper
• c-Jun N-TERMINAL KINASE BINDING DOMAIN – DEPENDENT PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 AND MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 AND BALANCING CROSS-TALK BETWEEN c-Jun N-TERMINAL KINASE AND EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAYS IN CORTICAL NEURONS

  2009influential citation
• Named Series : Biology of Microglia LPS-induced indoleamine 2 , 3-dioxygenase is regulated in an interferon-c-independent manner by a JNK signaling pathway in primary murine microglia

  2009cites this paper
• Cell-Penetrating Peptides Uptake, Toxicity, and Applications

  2009cites this paper
• Transportmoleculesusing reversesequenceHIV-Tat polypeptides:notjustanyold Tat?(WO200808225)

  2009cites this paper
• Uptake, Toxicity, and Applications

  2009cites this paper
• Peptides as signaling inhibitors for mammalian MAP kinase cascades.

  2009cites this paper
• Neuroinflammation and neuroprotective strategies in acute ischaemic stroke - from bench to bedside.

  2009cites this paper
• Limited role of the c‐Jun N‐terminal kinase pathway in a neonatal rat model of cerebral hypoxia–ischemia

  2009influential citation
• Perinatal asphyxia remains a frequent cause of neonatal mortality and is associated with increased neurological long- term morbidity (Volpe 2001). The discovery of safe and protective interventions for perinatal asphyxia and stroke remains an unmet goal of perinatal medicine (Northington

  2009cites this paper
• Transport molecules using reverse sequence HIV-Tat polypeptides: not just any old Tat? (WO200808225)

  2009cites this paper
• JNK Contributes to Hif-1α Regulation in Hypoxic Neurons

  2009cites this paper
• c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.

  2009cites this paper
• Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase

  2008cites this paper
• Specific JNK Inhibition by D-JNKI1 Protects Purkinje Cells from Cell Death in Lurcher Mutant Mouse

  2008cites this paper
• D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.

  2008cites this paper
• The JNK Inhibitor XG-102 Protects from Ischemic Damage with Delayed Intravenous Administration Also in the Presence of Recombinant Tissue Plasminogen Activator

  2008cites this paper